Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $1.8 million.

  • Jaguar Health's Change in Account Payables rose 30088.5% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 73289.47%. This contributed to the annual value of $328000.0 for FY2024, which is 13836.26% up from last year.
  • Per Jaguar Health's latest filing, its Change in Account Payables stood at $1.8 million for Q3 2025, which was up 30088.5% from -$438000.0 recorded in Q2 2025.
  • Jaguar Health's 5-year Change in Account Payables high stood at $1.9 million for Q2 2022, and its period low was -$1.7 million during Q1 2024.
  • For the 5-year period, Jaguar Health's Change in Account Payables averaged around $191052.6, with its median value being $259000.0 (2021).
  • In the last 5 years, Jaguar Health's Change in Account Payables plummeted by 151500.0% in 2021 and then surged by 64324.32% in 2022.
  • Jaguar Health's Change in Account Payables (Quarter) stood at $1.1 million in 2021, then crashed by 142.74% to -$489000.0 in 2022, then soared by 62.17% to -$185000.0 in 2023, then skyrocketed by 505.95% to $751000.0 in 2024, then soared by 141.28% to $1.8 million in 2025.
  • Its Change in Account Payables was $1.8 million in Q3 2025, compared to -$438000.0 in Q2 2025 and $1.7 million in Q1 2025.